Desialylation of O‐glycans activates von Willebrand factor by destabilizing its autoinhibitory module

Abstract

BackgroundThe binding of the A1 domain of von Willebrand factor (VWF) to platelet receptor glycoprotein (GP)Ibα defines the VWF activity in hemostasis. Recent studies suggest that sequences flanking A1 form cooperatively an autoinhibitory module (AIM) that reduces the accessibility of the GPIbα binding site on A1. Application of a tensile force induces unfolding of the AIM. Desialylation induces spontaneous binding of plasma VWF to platelets. Most O‐glycans in VWF are located around the A1 domain. Removing certain O‐glycans in the flanking sequences by site‐directed mutagenesis enhances A1 binding to GPIbα and produces an effect similar to type 2B von Willebrand disease in animals. ObjectivesTo understand if and how desialylation of O‐glycans in the flanking sequences increases A1 activity. MethodsA recombinant AIM‐A1 fragment encompassing VWF residues 1238–1493 and only O‐glycans was treated with neuraminidase to produce desialylated protein. The glycan structure, dynamics, stability, and function of the desialylated protein was characterized by biochemical and biophysical methods and compared to the sialylated fragment. ResultsAsialo‐AIM‐A1 exhibited increased binding activity and induced more apparent platelet aggregation than its sialylated counterpart. It exhibited a lower melting temperature, and increased hydrogen–deuterium exchange rates at residues near the secondary GPIbα binding site and the N‐terminal flanking sequence. Asialo‐AIM‐A1 is less mechanically stable than sialo‐AIM‐A1, with its unstressed unfolding rate approximately 3‐fold greater than the latter. ConclusionsDesialylation of O‐glycans around A1 increases its activity by destabilizing the AIM.